The growth retardation and outcomes with therapy (growth) study: A prospective evaluation in pediatric Crohn*s disease

Recruiting

• Conditions: Crohn's disease; Inflammatory Bowel Disease; 10017969

• Registration Number: NL-OMON37234
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 18 June 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

Newly diagnosed Crohn's disease, untill age of 18

Exclusion Criteria

Abdominal surgery, pregnancy and indeterminate colitis.

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary study parameters are clinical and therapeutic parameters that predict<br /><br>disease relapse and other outcomes of pediatric Crohn's disease such as linear<br /><br>growth, penetrating or stricturing disease and requirement for surgery. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>NA</p><br>